Skip to main content

Fetal Hematopoiesis

 "process by which cellular elements of blood are formed"

3 anatomical/developmental stages:

1.Mesoblastic (extraembryonic/ yolk sac)

  • Begins by 10-14th day
  • Ceases by 10-12 wk

2.Hepatic (liver)

  • By 6-8wk 1º site of hematopoiesis
  • Predominate site @ 20-24wks

3.Myeloid (bone marrow)

  • Starts increasingly from 2nd trimester
  • Macrophages produced earlier than neutrophils
  • ↑ gestation = ↓ macro : neutro ratio

Fetal granulopoises:

1st neutrophils appear 
  • @ 5th wk around aorta in clusters
Bone marrow space 
  • begins @8wk, 
  • enlarges 8-10wks, 
  • neutrophils in B.M 10.5wk
14wk - term: mc granulocytic cell ➵ Neutrophil
20wk: neutrophil count 0-500/mm3
Macrophage & neutrophil have common progenitor but macrophage appear early from yolk sac, liver, lung, 🧠.

Fetal thrombopoiesis:

BFU-MK (primitive)
  • large multifocal colonies➵50 megakaryocytes /colony
CFU-MK (differentiated)
  • unifocal colonies - 3-50 /colony
Fetal thrombopoiesis is biologically different from adult, 
  • rapid proliferation ➵ cytoplasmic maturation without polyploidization.
  • Significantly smaller
  • Lower ploidy (adult =16N, fetus=2N, Neonate=4N)
  • Fewer platelets are derived
Megakaryocytes ➵ endo reduplication ➵ large cells with polypoid nucleii
TPO: produced predominantly by Liver from fetal to adult life.

Fetal hematopoiesis:

EPO does not cross placenta
BFU-E: more proliferative➵more clusters
CFU-E: 1 or 2 clusters each with 8-100 hb erythroblasts
HIF (hypoxia induced factor)  ➵maintain O2 homeostasis & erythropoiesis by EPO
  • HIF 1α ,2α (regulated by O2 tension)
  • HIF 1β (constitutively expressed)
EPO
  • 1st & 2nd trimester ➵monocytes, macrophages
  • @birth ➵ by kidney (epigenetic switch)

Comments

Popular posts from this blog

Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines

Lab tests: Routine screening of family members of children with NCC is not recommended. If at all screening is performed, fecal testing of the family for ova/cyst can be done. The use of serological tests for diagnosis and clinical decision making in children with NCC is not recommended. Radiological tests: The MRI need not be done following CT in the following situations -  The CT conclusively demonstrates the presence of a scolex within the cyst  In the absence of demonstration of scolex – If a solitary cystic/ring-enhancing lesion has all other typical sizes, shape, and location characteristics of NCC Multiple lesions in different stages are present, including some cystic or ring enhancing or calcified MRI should be considered after CT in the following situations – Atypical imaging features (conglomerate lesions, subarachnoid or intraventricular lesions) along with the absence of scolex CT features create suspicion of intraventricular, subarachnoid, or intraspinal NCC Atypical clin